Uploaded on Jul 17, 2024
According to the latest research report by IMARC Group, The China genetic testing market size reached US$ 4.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.9 Billion by 2032, exhibiting a growth rate (CAGR) of 14.4% during 2024-2032. More Info:- https://www.imarcgroup.com/china-genetic-testing-market
China Genetic Testing Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
China Genetic Testing
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
Acco r d ing t o t h e l a t es t r epo r t by I M A RC G r oup , t i t l e d " Ch i na G enet i c Tes t i ng
M ar ke t : I nd ust ry T r ends , Sha re , S i ze , G row t h , O ppo r t un i t y a nd For ecas t 202 4 -
2032 , " t he Ch in a gen e t i c t es t i n g m a r ke t s i ze r eac hed US$ 4 . 3 B i l l i on i n 2023 .
G en e t i c t es t s i den t i f y t he chan ges occu r r i ng i n t he g enes , p r o t e ins o r c h r om oso m es
Report o f an i nd i v idu a l . The y he lp i n de t e r m in i ng t he chan ces o f a pe r son pas s ing on a
gene t i c d i so r de r t o t h e nex t gene r a t i o n as w e l l as t he i r vu lne r a b i l i t y t o a su spec t ed
gene t i c d i seas e . The gen e t i c t es t i ng m a r ke t i n Ch ina h as w i t ness ed r ap id
Highlight and dev e l opm en t s ince t he es t ab l i shm e n t o f t he f i r s t ge nom ic s com pan y i n 1 999 .
The dem and f o r ge ne t i c t es t i ng se r v i ces i n t he cou n t r y i s be ing d r i ven by f ac t o r s
Description l i ke ag i ng p opu l a t i on , ex pan d ing m idd le c las s a nd in ves t m en t s i n t h e he a l t hc a r e
sec t o r . The i nd us t r y h as a l so a t t r a c t ed i n t e r na t i o na l i n ves t o r s o w ing t o r i s i ng
dem and f o r no n inva s i ve p r e na t a l t es t i ng and g r ow ing r ese a r ch i n t he f i e l ds o f
r ep r oduc t i ve a nd o nco log y hea l t h .
Reque st f o r a P DF s ampl e o f t h i s repor t :
h t t p s : / / www. im ar c g r ou p . com / ch i na - gen e t i c - t es t i ng - m ar ke t / r eq ues t sam p le
Report Description
China Genet ic Test ing Market Trends :
In an e f fo r t t o expand i t s domest ic b io techno logy sec to r , t he Ch inese Government has taken s teps in the favor o f
gene t i c sc ience deve lopment . I t iden t i f i ed genomics as a s t ra teg ic f i e ld fo r t he coun t ry ’ s soc ia l and economic
deve lopment in i t s 14 th F ive -Year P lan . The Government a lso p lans to document the gene t i c makeup o f peop le
f rom n ine d i f f e ren t m inor i t y g roups , in an a t tempt to decode hered i ta ry in fo rma t ion w i th in the i r genes .
Apa r t f rom th is , t he marke t f o r d i rec t - to -consumer DNA tes t ing has a lso exper ienced mass ive g rowth d r i ven by
r i s ing p r io r i t y o f pe rsona l hea l th and we l lness among consumers . Th is t rend has fu r the r been suppor ted by
techno log ica l advancements wh ich have reduced the cos t o f DNA sequenc ing se rv i ces . However , t he re is a lack
o f spec i f i ca l l y -des igned educa t iona l p rograms fo r t ra in ing med ica l gene t i c p ro fess iona ls in Ch ina .
Look ing forward, the market va lue is expected to reach US$ 14 .9 B i l l ion by 2032 , exhib i t ing a CAGR of
14 .4% dur ing 2024-2032 .
V iew Repor t TOC, F igures and Tables : h t tps: / /www. imarcgroup.com/china-genet ic - tes t ing-market
Breakup by Test Type:
• Prenatal Test ing
• Carr ier Test ing
• New Born Test ing
• Predict ive/Presymptomatic Test ing
• Diagnost ic Test ing
• Others
Report
Segmentation Breakup by Disease:
• Cancer
• Down Syndrome
• Thalassemia
• Others
Breakup by Technology:
• Biochemical
• Molecular
• Cytogenetic
Breakup by Service Provider:
• Hospital Based Laboratories
• Independent Laboratories
Report • Specialty Cl inics
Segmentation Breakup by Testing Sample:
• Blood
• Sal iva
• Hair
• Others
• BGI
• Berry Genomics Co. l td.
• Daan Gene Co. Ltd
Competitive • WuXi NextCODE
Landscape • Annoroad Gene Technology Co. Ltd.
with Key • WuXi PharmaTech
Players
What was the size of the China genetic testing
market in 2023?
What is the expected growth rate of the China
genetic testing market during 2024-2032?
Key
Questions What are the key factors driving the China genetic testing market?
Answered in
What has been the impact of COVID-19 on the
the Report China genetic testing market?
What is the breakup of the China genetic testing
market based on the test type?
What is the breakup of the China genetic testing
market based on the disease?
What is the breakup of the China genetic testing
market based on technology?
What is the breakup of the China genetic testing
market based on the service provider?
Key
Questions What is the breakup of the China genetic testing market based on the testing sample?
Answered in
Who are the key players/companies in the China
the Report genetic testing market?
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
2 . 4 . 1 B o t t o m - U p A p p r o a c h
Table of 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 I n t r o d u c t i o n
4 . 1 O v e r v i e w
Contents 4 . 2 K e y I n d u s t r y T r e n d s5 C h i n a G e n e t i c T e s t i n g M a r k e t
5 . 1 M a r k e t O v e r v i e w
5 . 2 M a r k e t P e r f o r m a n c e
5 . 3 I m p a c t o f C O V I D - 1 9
5 . 4 M a r k e t B r e a k u p b y T e s t T y p e
5 . 5 M a r k e t B r e a k u p b y D i s e a s e
5 . 6 M a r k e t B r e a k u p b y T e c h n o l o g y
5 . 7 M a r k e t B r e a k u p b y S e r v i c e P r o v i d e r
5 . 8 M a r k e t B r e a k u p b y T e s t i n g S a m p l e
5 . 9 M a r k e t F o r e c a s t
5 . 1 0 S W O T A n a l y s i s
5 . 1 0 . 1 O v e r v i e w
5 . 1 0 . 2 S t r e n g t h s
5 . 1 0 . 3 W e a k n e s s e s
5 . 1 0 . 4 O p p o r t u n i t i e s
5 . 1 0 . 5 T h r e a t s
5 . 1 1 V a l u e C h a i n A n a l y s i s
5 . 1 1 . 1 R e s e a r c h a n d D e v e l o p m e n t
5 . 1 1 . 2 E q u i p m e n t ' s P r o c u r e m e n t
5 . 1 1 . 3 S a m p l e s C o l l e c t i o n
5 . 1 1 . 4 G e n e t i c T e s t i n g
5 . 1 1 . 5 D a t a A n a l y s i s a n d I n t e r p r e t a t i o n
5 . 1 1 . 6 R e c e i v i n g C o m p r e h e n s i v e
5 . 1 1 . 7 C l i n i c a l R e p o r t
5 . 1 2 P o r t e r s F i v e F o r c e s A n a l y s i s
5 . 1 2 . 1 O v e r v i e w
5 . 1 2 . 2 B a r g a i n i n g P o w e r o f B u y e r s
Table of 5 . 1 2 . 3 B a r g a i n i n g P o w e r o f S u p p l i e r s 5 . 1 2 . 4 D e g r e e o f C o m p e t i t i o n
5 . 1 2 . 5 T h r e a t o f N e w E n t r a n t s
5 . 1 2 . 6 T h r e a t o f S u b s t i t u t e s
Contents 5 . 1 3 K e y S u c c e s s a n d R i s k F a c t o r s
6 M a r k e t B r e a k u p b y T e s t T y p e
6 . 1 P r e n a t a l T e s t i n g
6 . 1 . 1 M a r k e t T r e n d s
6 . 1 . 2 M a r k e t F o r e c a s t
6 . 2 C a r r i e r T e s t i n g
6 . 2 . 1 M a r k e t T r e n d s
6 . 2 . 2 M a r k e t F o r e c a s t
6 . 3 N e w B o r n T e s t i n g
6 . 3 . 1 M a r k e t T r e n d s
6 . 3 . 2 M a r k e t F o r e c a s t
6 . 4 P r e d i c t i v e / P r e s y m p t o m a t i c T e s t i n g
6 . 4 . 1 M a r k e t T r e n d s
6 . 4 . 2 M a r k e t F o r e c a s t
F o r m o r e i n f o r m a t i o n , v i s i t :
ht t ps : / /w ww. i ma rc gro up . c o m /c h in a -g ene t i c - t e s t i ng -m a rke t / t o
c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us:
Comments